Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Hastings Technology Metals Limited ( (AU:HAS) ) is now available.
Hastings has outlined the proprietary caustic-leach hydrometallurgical flowsheet for its Kabin Buri Hydromet Plant in Thailand, which will process African monazite concentrate into premium mixed rare earth chloride (MREC) flake. The plant, located in Thailand’s low-cost Eastern Economic Corridor, is designed as a strategic midstream hub that complements the Yangibana project and advances Hastings’ vertically integrated rare earths strategy.
The company expects to complete the hydromet plant acquisition and initial 5,000 tpa input capacity commissioning by June 2026, targeting first MREC production in Q4 2026. Unaudited estimates point to Year 1 revenue of about US$53.4 million and pretax profit of US$21.6 million, rising to US$106.8 million revenue and US$43.8 million pretax profit from Year 2 after a low-cost expansion, positioning Hastings for earlier cash flow and stronger participation in the global rare earths supply chain.
The most recent analyst rating on (AU:HAS) stock is a Hold with a A$0.55 price target. To see the full list of analyst forecasts on Hastings Technology Metals Limited stock, see the AU:HAS Stock Forecast page.
More about Hastings Technology Metals Limited
Hastings Technology Metals is an Australian rare earths company focused on developing the Yangibana Rare Earths and Niobium Joint Venture project in Western Australia and expanding into midstream processing. The company is building a vertically integrated, mine-to-market position, with a new hydrometallurgical plant in Thailand aimed at producing mixed rare earth chloride for global oxide separators.
Average Trading Volume: 362,326
Technical Sentiment Signal: Hold
Current Market Cap: A$109.9M
See more insights into HAS stock on TipRanks’ Stock Analysis page.

